Company Overview
Snapshot
Founded in March 2022 by Miriam Haart, ActionAI operates with 11–50 employees. The company has successfully completed one funding round, securing $10M in total capital raised. In April 2026, ActionAI announced a significant $10M Seed funding round.
Business overview
ActionAI provides an AI automation platform designed for mission-critical enterprise workflows across operations, finance, legal, logistics, manufacturing, and regulated industries. Its Action Platform enables teams to build and deploy AI automations, connect agents and logic, validate outputs against ground truth, and route low-confidence cases to human reviewers, maintaining audit-ready decision trails. The platform serves use cases such as invoice processing, reconciliation, internal auditing, procurement validation, evidence classification, regulatory compliance, and legal verdict drafting, operating within the Business Software sector with a focus on Artificial Intelligence and Enterprise & Professional Services.
Strategic signal
ActionAI's recent $10M Seed funding round in April 2026 highlights investor confidence in its AI automation platform. This capital infusion signals a strong market validation for its approach to tackling the AI trust gap in enterprise workflows, positioning the company for accelerated development and market expansion, particularly in high-stakes environments where accuracy and auditability are paramount.
Company Intelligence Q&A
- When was ActionAI founded?
- ActionAI was founded in March 2022.
- Who is the founder of ActionAI?
- Miriam Haart is the founder of ActionAI.
- What was ActionAI's most recent funding event?
- In April 2026, ActionAI raised a $10M Seed funding round, as reported by The SaaS News and IsraelDefense.co.il.
- What is ActionAI's primary business focus?
- ActionAI develops an AI automation platform for mission-critical enterprise workflows, focusing on areas like operations, finance, legal, and manufacturing.
- Where are ActionAI's main offices located?
- ActionAI has offices in Ramat Gan, Israel, and New York, NY, USA.